Fermentalg Accelerates Transformation to Support Financial Goals

Libourne, February 6, 2024 - Fermentalg, a leader in bio-solutions with a focus on aquatic micro-organisms, has announced progress in its strategic transformation. Initiated by CEO Pierre Josselin, this change aims to enhance its market position in biotechnology, backed by 200 patents and collaborations with industry giants like HuvePharma.

The company aims to strengthen its sales structure to boost growth in key markets such as the United States and China. It targets five strategic segments, including dietary supplements, infant nutrition, functional food, pet food, and cosmetics. Each segment offers significant market opportunities.

Fermentalg plans to multiply its sales sixfold by 2026 and achieve break-even by the same year. Its financial strategy includes new product industrialization and cost optimization. The company remains committed to innovation and sustainability, with a goal to decarbonize by 2030.